128 related articles for article (PubMed ID: 2907464)
1. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat.
Singh K; Orr JM; Abbott FS
Drug Metab Dispos; 1988; 16(6):848-52. PubMed ID: 2907464
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and enterohepatic circulation of (E)-2-ene valproic acid in the rat.
Singh K; Orr JM; Abbott FS
J Pharmacobiodyn; 1990 Oct; 13(10):622-7. PubMed ID: 2095402
[TBL] [Abstract][Full Text] [Related]
3. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics.
Tang W; Abbott FS
Drug Metab Dispos; 1997 Feb; 25(2):219-27. PubMed ID: 9029053
[TBL] [Abstract][Full Text] [Related]
4. Capillary GCMS assay of 2-n-propyl-4-pentenoic acid (4-ene VPA) in rat plasma and urine.
Singh K; Abbott FS; Orr JM
Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):211-23. PubMed ID: 3602586
[TBL] [Abstract][Full Text] [Related]
5. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
Kassahun K; Abbott F
Drug Metab Dispos; 1993; 21(6):1098-106. PubMed ID: 7905390
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
Tang W; Borel AG; Fujimiya T; Abbott FS
Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
[TBL] [Abstract][Full Text] [Related]
7. Choleretic effect of valproic acid in the rat.
Watkins JB; Klaassen CD
Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
[TBL] [Abstract][Full Text] [Related]
8. Nonlinear elimination and cholerteic effect of valproic acid in the monkey.
Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL
J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022
[TBL] [Abstract][Full Text] [Related]
9. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
[TBL] [Abstract][Full Text] [Related]
11. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.
Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P
Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269
[TBL] [Abstract][Full Text] [Related]
12. The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes.
Porubek DJ; Grillo MP; Baillie TA
Drug Metab Dispos; 1989; 17(2):123-30. PubMed ID: 2565201
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.
Liu MJ; Brouwer KL; Pollack GM
Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
Kassahun K; Farrell K; Abbott F
Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
[TBL] [Abstract][Full Text] [Related]
15. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.
Wright AW; Dickinson RG
J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379
[TBL] [Abstract][Full Text] [Related]
16. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
17. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry.
Tang W; Abbott FS
J Mass Spectrom; 1996 Aug; 31(8):926-36. PubMed ID: 8799319
[TBL] [Abstract][Full Text] [Related]
18. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H
Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
[TBL] [Abstract][Full Text] [Related]
19. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
Rettenmeier AW; Prickett KS; Gordon WP; Bjorge SM; Chang SL; Levy RH; Baillie TA
Drug Metab Dispos; 1985; 13(1):81-96. PubMed ID: 2858383
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.
Kassahun K; Hu P; Grillo MP; Davis MR; Jin L; Baillie TA
Chem Biol Interact; 1994 Mar; 90(3):253-75. PubMed ID: 8168173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
